Structured evidence table for Inositol Metabolic Health Systematic Review, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Inositol Metabolic Health Systematic Review | Maternal hyperglycaemia increases offspring risk of metabolic disorders through epigenetic, hormonal and developmental programming. | 1 | Wu Y (2026) | Long-term metabolic consequences of <i>in-utero</i> gestational diabetes exposure and maternal treatment interventions: a systematic review and meta-analysis. |
| Inositol Metabolic Health Systematic Review | Growing evidence connects prenatal GDM exposure to childhood and adult metabolic diseases, yet the consistency and magnitude of these associations across different metabolic conditions remains unclear. | 1 | Wu Y (2026) | Long-term metabolic consequences of <i>in-utero</i> gestational diabetes exposure and maternal treatment interventions: a systematic review and meta-analysis. |
| Inositol Metabolic Health Systematic Review | Bias risk was evaluated with Cochrane RoB 2 (for RCTs) and the Newcastle-Ottawa Scale (NOS) (for observational studies). | 1 | Wu Y (2026) | Long-term metabolic consequences of <i>in-utero</i> gestational diabetes exposure and maternal treatment interventions: a systematic review and meta-analysis. |
| Inositol Metabolic Health Systematic Review | Background Gestational diabetes mellitus (GDM) affects 14-17% of pregnancies globally, imposing long-term public health burdens beyond pregnancy. | 1 | Wu Y (2026) | Long-term metabolic consequences of <i>in-utero</i> gestational diabetes exposure and maternal treatment interventions: a systematic review and meta-analysis. |
| Inositol Metabolic Health Systematic Review | Insulin resistance is a key pathogenetic factor contributing to ovarian dysfunction and reduced fertility. | 3 | Habryka J (2026) | Effect of Myo-Inositol Supplementation in Polycystic Ovary Syndrome-Scoping Review. |
| Inositol Metabolic Health Systematic Review | This scoping review aimed to map the available scientific literature on the effects of MI supplementation in women with PCOS, with particular emphasis on fertility and ovarian function, and to identify gaps in the current evidence base. | 3 | Habryka J (2026) | Effect of Myo-Inositol Supplementation in Polycystic Ovary Syndrome-Scoping Review. |
| Inositol Metabolic Health Systematic Review | Results : Of the 77 records initially identified, 13 studies were included in the review, and no duplicates were found. | 3 | Habryka J (2026) | Effect of Myo-Inositol Supplementation in Polycystic Ovary Syndrome-Scoping Review. |
| Inositol Metabolic Health Systematic Review | Objectives : Polycystic ovary syndrome (PCOS) is a widespread and complex endocrine disorder affecting women of childbearing potential, characterized by reproductive dysfunction, hyperandrogenism, and metabolic disorders, including insulin resistance. | 3 | Habryka J (2026) | Effect of Myo-Inositol Supplementation in Polycystic Ovary Syndrome-Scoping Review. |
Source documents